What others say about PharmaPendium

Identification of structure–activity: Part A

Authored by: Carling J. Ursem, Naomi L. Kruhlak, Joseph F. Contrera, Philip M. MacLaughlin, R. Daniel Benz, Edwin J. Matthews

Authored Date: Tue, 08/07/2008

Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities

Identification-of-structure-activity-Part-A.pdf

Identification of structure–activity: Part B

Authored by: Edwin J. Matthews, Carling J. Ursem, Naomi L. Kruhlak, R. Daniel Benz, David Aragones Sabate, Chihae Yang, Gilles Klopman, Joseph F. Contrera

Authored Date: Wed, 09/07/2008

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities (2 parts on SD)

Identification-of-structure-activity-Part-B.pdf

Mapping Adverse Drug Reactions in Chemical Space

Authored by: Josef Scheiber, Jeremy L. Jenkins, Sai Chetan K. Sukuru†, Andreas Bender, Dmitri Mikhailov, Mariusz Milik, Kamal Azzaoui, Steven Whitebread, Jacques Hamon, Laszlo Urban, Meir Glick and John W. Davies

Authored Date: Mon, 20/04/2009

Find out how the authors of ‘Mapping Adverse Drug Reactions in Chemical Space’ published in the Journal of Medicinal Chemistry in April 2009, used PharmaPendium in their research and analysis into adverse drug reactions in chemical space.